PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus |
| Phenotype | C0022658|renal disease |
| Sentences | 30 |
| PubMedID- 20685548 | This article discusses renal physiology and assessment of renal function in pregnancy and the effect of pregnancy on renal disease in patients with diabetes, lupus, chronic glomerulonephritis, polycystic kidney disease, and chronic pyelonephritis. |
| PubMedID- 25692867 | Sociodemographic and geographic predictors of quality of care in united states patients with end-stage renal disease due to lupus nephritis. |
| PubMedID- 20395647 | Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus. |
| PubMedID- 21336956 | Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease. |
| PubMedID- 25860678 | We have identified two groups of patients: group 1 involving systemic lupus erythematosus without renal disease, group 2 : patient with lupus nephritis. |
| PubMedID- 20972695 | We excluded patients for whom steroids were contraindicated and also those in whom the renal disease was associated with systemic lupus erythematosus or other systemic diseases. |
| PubMedID- 25251922 | Patients with end-stage renal disease due to lupus nephritis. |
| PubMedID- 22134565 | Objective: the aim was to assess the level of systemic involvement and character of renal disease in patients with chronic cutaneous lupus erythematosus of the discoid lupus variety (hereafter referred to as 'discoid lupus') and features of systemic lupus erythematosus (sle). |
| PubMedID- 20039429 | Mycophenolate mofetil is, therefore, a suitable alternative to cyclophosphamide for the treatment of renal and nonrenal disease manifestations in patients with biopsy-proven lupus nephritis. |
| PubMedID- 23213597 | We report the case of a 42-year-old women with end-stage renal disease due to lupus nephritis and a history of bilateral thrombosis of iliac arteries caused by antiphospholipid antibodies. |
| PubMedID- 25624071 | Racial and ethnic differences in mortality and cardiovascular events among patients with end-stage renal disease due to lupus nephritis. |
| PubMedID- 22566947 | Higher levels of igm antiphospholipid antibodies that bind to beta-2-glycoprotein i (β2-gpi) and cardiolipin in lupus patients correlated with less frequent renal disease manifestations (mehrani and petri, 2011; gronwall et al., 2012). |
| PubMedID- 25018941 | Relationship between anti-double-stranded dna antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. |
| PubMedID- 26131446 | A 49-year-old, chronic alcoholic male with a previous medical history of end-stage renal disease due to lupus nephritis (world health organization class iv) and who had been receiving hemodialysis for the past 3.5 years through a left forearm arteriovenous fistula, as well as having dilated cardiomyopathy and atrial fibrillation, was admitted to asan medical center because of massive painful swelling of the right thigh and high fever. |
| PubMedID- 23940824 | A 30 year old african american female underwent deceased donor kidney transplant for end stage renal disease due to systemic lupus erythematosus. |
| PubMedID- 21532056 | Mannose-binding lectin expression genotype in pediatric-onset systemic lupus erythematosus: associations with susceptibility to renal disease and protection against infections. |
| PubMedID- 22058067 | Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the united states. |
| PubMedID- 24097970 | The follow-up data were obtained, and the analysis was conducted to determine the effect of interstitial inflammation on the rate of the doubling of serum creatinine or end-stage renal disease (esrd) in patients with lupus nephritis. |
| PubMedID- 21716195 | Case report: a 35-year old african american female with end stage renal disease due to lupus nephritis received a living related renal transplant from a brother. |
| PubMedID- 22415467 | Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. |
| PubMedID- 21445962 | Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the us from 1995 to 2006. |
| PubMedID- 21059275 | A recently published, multicenter, randomized clinical trial showed that mmf is a suitable alternative to cyc for the treatment of renal and non-renal disease manifestations in patients with biopsy-proven lupus nephritis [26]. |
| PubMedID- 26396262 | Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study. |
| PubMedID- 26002293 | Background: a recent study showed an increased risk of death in african americans compared with whites with end-stage renal disease (esrd) due to lupus nephritis (ln). |
| PubMedID- 20497629 | Objectives: to evaluate change over time and level of agreement of renal-specific and multi-dimensional measures in juvenile systemic lupus erythematosus (sle) with renal disease. |
| PubMedID- 25582448 | We report a patient suffering from end-stage renal disease (esrd) because of lupus nephritis presented with exhausted vascular access after multiple arteriovenous grafts creation and hemodialysis catheters insertion. |
| PubMedID- 24068666 | Autoantibody production and immune complex deposition within the kidney promote renal disease in patients with lupus nephritis. |
| PubMedID- 23281889 | The incidence of end-stage renal disease attributable to lupus nephritis has not declined over the decades [31,32]. |
| PubMedID- 21445963 | End-stage renal disease due to lupus nephritis among children in the us, 1995-2006. |
| PubMedID- 25884409 | Background: patients with end-stage renal disease (esrd) due to lupus nephritis (ln-esrd) may be followed by multiple providers (nephrologists and rheumatologists) and have greater opportunities to receive recommended esrd-related care. |
Page: 1